Target intelligence / Profile preview

Ribosomal protein S5 (S5)

Target
S5
Molecular classification
Ribosomal protein, Small ribosomal subunit protein (bacterial 30S), Protein component of the translation machinery
01

Overview

Ribosomal protein S5 is a highly conserved protein component of the bacterial small ribosomal subunit (30S), essential for accurate translation and assembly of the ribosome[1][5][6][9][10]. S5 structurally interacts with rRNA and several ribosomal proteins, contributing to the formation of tRNA- and mRNA-binding sites essential for protein synthesis[1][2][4][5][7]. Mutations in S5 can affect translational fidelity, resulting in frameshifting and suppression phenotypes[2][10], and may alter susceptibility to ribosome-targeting antibiotics[1][7]. Ribosomal protein S5 is thus a validated antibacterial drug target, with several antibiotics acting through disruption of the small subunit function or structure[7][8]. While S5 is not used as a clinical biomarker and does not have known human expression, its centrality in translation makes it critical to bacterial cell viability and antibiotic response.

Other names
30S ribosomal protein S5Small ribosomal subunit protein uS5RPS5 (less common in bacterial context)
02

Mechanism of action

Inhibition of protein synthesis by locking ribosome in an inactive state or inducing misreading of mRNA through interaction with ribosome Maintenance/disruption of translational fidelity and assembly of the ribosome

03

Biological functions

Ribosome assemblyMaintenance of translational fidelityProtein biosynthesis (translation)Formation and stabilization of mRNA and tRNA binding sites on ribosomePossibly involved in cell physiology beyond canonical ribosomal roles
04

Disease associations

Infection (bacterial ribosomes are primary targets of antibiotics)Other (alterations in ribosomal proteins can impact cell growth, translation fidelity, and antibiotic susceptibility)
05

Safety considerations

Broad inhibition of ribosome can be toxic to host if selectivity for bacterial ribosome is insufficientMutations in S5 can cause alterations in antibiotic susceptibility and translation accuracy
06

Interacting drugs

Aminoglycoside antibiotics (e.g., paromomycin)

1 more in the full profile.

07

Biomarkers

None well-established for S5 specifically

Beyond the preview

Go deeper on Ribosomal protein S5 (S5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S5 (S5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call